TMCI
Treace Medical Concepts Inc
3.90$
-2.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 19.6% | 18.4% | 19.8% | 19.8% | 19.9% | 19.3% | 20.3% | 20.3% | 20.9% | 19.4% | 20.7% | 21.5% | 20.5% | |
| 80.4% | 81.6% | 80.2% | 80.2% | 80.1% | 80.7% | 79.7% | 79.7% | 79.1% | 80.6% | 79.3% | 78.5% | 79.5% | |
| 10.7% | 6.7% | 10.3% | 11.6% | 11.0% | 7.6% | 10.6% | 11.6% | 9.3% | 7.3% | 9.8% | 9.6% | 8.9% | |
| 31.1% | 21.6% | 28.1% | 32.0% | 30.0% | 19.8% | 30.0% | 34.1% | 32.4% | 23.2% | 34.3% | 33.6% | 30.3% | |
| 124.1% | 92.5% | 117.3% | 128.3% | 113.7% | 81.0% | 109.3% | 115.5% | 110.3% | 90.1% | 115.6% | 111.4% | 105.6% | |
| -43.7% | -10.9% | -37.1% | -48.1% | -33.6% | -0.3% | -29.6% | -35.8% | -31.2% | -9.5% | -36.4% | -33.0% | -26.2% | |
| 3.2% | 2.1% | 2.6% | 3.0% | 2.9% | 1.9% | 2.5% | 2.8% | 2.7% | 2.2% | 3.3% | 3.4% | 2.8% | |
| -43.0% | -10.1% | -36.5% | -47.7% | -34.1% | -0.7% | -30.3% | -36.7% | -32.4% | -15.0% | -38.1% | -35.0% | -29.0% | |
| -3.8% | 0.8% | 3.7% | – | -4.8% | – | – | – | – | – | – | – | – | |
| -43.0% | -10.1% | -36.5% | -47.7% | -34.1% | -0.7% | -30.3% | -36.7% | -32.4% | -15.0% | -38.1% | -35.0% | -29.0% | |
| -36.0% | -5.2% | -30.2% | -40.0% | -26.4% | 4.4% | -23.1% | -28.5% | -24.2% | -8.3% | -32.8% | -27.4% | -22.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.